Prostate cancer (PCa) is a common cancer in men, requiring accurate diagnosis and monitoring of treatment efficacy for in time revealing and eliminating cancer relapse. Radical prostatectomy is the ...

This study aims to compare the perioperative outcomes, postoperative urinary control rates, and positive surgical margin (PSM) rates of robot-assisted laparoscopic radical prostatectomy using a ...

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

Recent advancements in radiological imaging have raised the possibility of diagnosing prostate cancer (PCa) without biopsy; however, the safety, feasibility, and diagnostic accuracy of this approach ...

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We conducted a ...

A pretreatment MRI in men undergoing radical prostatectomy can provide independent prognostic value for oncologic outcomes, a systematic review and meta-analysis indicated. MRI-detected extraprostatic ...

Radical prostatectomy does not ensure a cure, with one in three men experiencing cancer recurrence and elevated PSA levels within 10 years post-surgery. Significant side effects of prostate removal ...

Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...

Evaluation of the safety and efficacy of daily oral Angelica gigas Nakai (AGN)-INM176 in prostate cancer patients with rising plasma PSA (phase I/II trial). This is an ASCO Meeting Abstract from the ...

With long-term follow-up, mpMRI-guided salvage radiotherapy achieved excellent durable local control. The absence of in-field ...

PSMA PET has become central to prostate cancer imaging as advanced disease incidence rises and prostate-specific membrane ...

Prostate cancer surgeons routinely use MRI to guide surgical planning, yet imaging findings are not used for risk stratification in standard prognostic models. A new meta-analysis suggests they should ...